Incidence and predictors of hospital readmission in children presenting with severe anaemia in Uganda and Malawi :

dc.contributor.authorConnon, Roisin
dc.contributor.authorGeorge, Elizabeth C.
dc.contributor.authorOlupot-Olupot, Peter
dc.contributor.authorKiguli, Sarah
dc.contributor.authorChagaluka, George
dc.contributor.authorAlaroker, Florence
dc.contributor.authorOpoka, Robert O.
dc.contributor.authorMpoya, Ayub
dc.date.accessioned2021-09-28T06:23:39Z
dc.date.available2021-09-28T06:23:39Z
dc.date.issued2021
dc.descriptionArticleen_US
dc.description.abstractBackground: Severe anaemia (haemoglobin < 6 g/dL) is a leading cause of recurrent hospitalisation in African children. We investigated predictors of readmission in children hospitalised with severe anaemia in the TRACT trial (ISRCTN84086586) in order to identify potential future interventions. Methods: Secondary analyses of the trial examined 3894 children from Uganda and Malawi surviving a hospital episode of severe anaemia. Predictors of all-cause readmission within 180 days of discharge were identified using multivariable regression with death as a competing risk. Groups of children with similar characteristics were identified using hierarchical clustering. Results: Of the 3894 survivors 682 (18%) were readmitted; 403 (10%) had ≥2 re-admissions over 180 days. Three main causes of readmission were identified: severe anaemia (n = 456), malaria (n = 252) and haemoglobinuria/dark urine syndrome (n = 165). Overall, factors increasing risk of readmission included HIV-infection (hazard ratio 2.48 (95% CI 1.63–3.78), p < 0.001); ≥2 hospital admissions in the preceding 12 months (1.44(1.19–1.74), p < 0.001); history of transfusion (1.48(1.13–1.93), p = 0.005); and missing ≥1 trial medication dose (proxy for care quality) (1.43 (1.21–1.69), p < 0.001). Children with uncomplicated severe anaemia (Hb 4-6 g/dL and no severity features), who never received a transfusion (per trial protocol) during the initial admission had a substantially lower risk of readmission (0.67(0.47–0.96), p = 0.04). Malaria (among children with no prior history of transfusion) (0.60(0.47–0.76), p < 0.001); younger-age (1.07 (1.03–1.10) per 1 year younger, p < 0.001) and known sickle cell disease (0.62(0.46–0.82), p = 0.001) also decreased risk of readmission. For anaemia re-admissions, gross splenomegaly and enlarged spleen increased risk by 1.73(1.23–2.44) and 1.46(1.18–1.82) respectively compared to no splenomegaly. Clustering identified four groups of children with readmission rates from 14 to 20%. The cluster with the highest readmission rate was characterised by very low haemoglobin (mean 3.6 g/dL). Sickle Cell Disease (SCD) predominated in two clusters associated with chronic repeated admissions or severe, acute presentations in largely undiagnosed SCD. The final cluster had high rates of malaria (78%), severity signs and very low platelet count, consistent with acute severe malaria. Conclusions: Younger age, HIV infection and history of previous hospital admissions predicted increased risk of readmission. However, no obvious clinical factors for intervention were identified. As missing medication doses was highly predictive, attention to care related factors may be important. Keywords: Severe anaemia, Readmissionen_US
dc.description.sponsorshipBusitema University, BMC Public Healthen_US
dc.identifier.citationConnon, Roisin . . . [et al.]. (2021). Incidence and predictors of hospital readmission in children presenting with severe anaemia in Uganda and Malawi: a secondary analysis of TRACT trial data. https://doi.org/10.1186/s12889-021-11481-6en_US
dc.identifier.urihttps://doi.org/10.60682/asts-4073
dc.language.isoenen_US
dc.publisherBusitema University ; BMC Public Healthen_US
dc.subjectRecurrent hospitalisationen_US
dc.subjectAfrican childrenen_US
dc.subjectSevere anaemiaen_US
dc.subjectReadmissionen_US
dc.titleIncidence and predictors of hospital readmission in children presenting with severe anaemia in Uganda and Malawi :en_US
dc.title.alternativea secondary analysis of TRACT trial dataen_US
dc.typeArticleen_US